ASCO 2022: NK cell activity and methylated HOXA9 circulating tumor DNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Aktivitet: Foredrag og mundtlige bidragKonferenceoplæg

Beskrivelse

Poster presentation
Periode3. jun. 2022
Begivenhedstitel2022 ASCO annual meeting
BegivenhedstypeKonference
PlaceringChicago, USA, IllinoisVis på kort
Grad af anerkendelseInternational